Page last updated: 2024-09-04

cyc 202 and 2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole

cyc 202 has been researched along with 2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole in 2 studies

Compound Research Comparison

Studies (cyc 202)	Trials (cyc 202)	Recent Studies (post-2010) (cyc 202)	Studies (2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole)	Trials (2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole)	Recent Studies (post-2010) (2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole)
979	7	393	7	0	3

Protein Interaction Comparison

Protein	Taxonomy	2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole (IC50)
G2/mitotic-specific cyclin-B2	Homo sapiens (human)	10
Cyclin-dependent kinase 1	Homo sapiens (human)	10
G2/mitotic-specific cyclin-B1	Homo sapiens (human)	10
Glycogen synthase kinase-3 alpha	Homo sapiens (human)	4.195
Glycogen synthase kinase-3 beta	Homo sapiens (human)	1.725
G2/mitotic-specific cyclin-B3	Homo sapiens (human)	10

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H	1
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M	1

Other Studies

2 other study(ies) available for cyc 202 and 2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole

Article	Year
Identifying off-target effects and hidden phenotypes of drugs in human cells. Nature chemical biology, 2006, Volume: 2, Issue:6 Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship	2006
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51 Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases	2007

Article

Year

Identifying off-target effects and hidden phenotypes of drugs in human cells.

Nature chemical biology, 2006, Volume: 2, Issue:6

Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship

2006

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.

Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007